Cultured Meat Market to Reach $229 Billion by 2035 at 31% CAGR | Aleph Farms, UPSIDE Foods, Mosa Meat Among Key Players

The global cultured meat market, valued at USD 0.27 billion in 2025, is projected to reach USD 0.34 billion in 2026 and USD 229 billion by 2035, with a 31% CAGR during the forecast period 2026 to 2050, growing at a compound annual growth rate of 31% over the forecast period. This growth trajectory reflects a fundamental shift in how the world produces and consumes protein, driven by a collision of environmental pressure, population growth, and regulatory progress that is reshaping the food industry from the ground up.

To explore the complete findings, request a free sample of the report at https://www.rootsanalysis.com/reports/cultured-meat-market/request-sample.html

Market Overview
Cultured meat, also called cultivated meat or cell-based meat, is produced by growing animal stem cells in bioreactors using cell culture media, entirely outside a living animal. The process eliminates the need for industrial slaughter while delivering a product nutritionally comparable to conventional meat. At its core, the technology addresses one of the most pressing supply-demand imbalances in modern food systems: the world population is projected to reach 9.8 billion by 2050, and the global appetite for meat is rising sharply alongside it.

Conventional livestock farming cannot close that gap without severe environmental cost. Currently, roughly three-quarters of global agricultural land is allocated to animal farming, and approximately 60% of greenhouse gas emissions from food production originate from meat production alone. Cultured meat requires a fraction of the land and water that traditional production demands, making it one of the most credible solutions available to food security planners and sustainability investors right now.

The investment community has taken notice. Cultured meat companies have raised a cumulative total exceeding USD 2.4 billion since 2020, with the single largest round being a USD 347 million Series B closed by Believer Meats in December 2021, backed by ADM, S2G Ventures, and Menora Mivtachim. In April 2026, JBS opened a USD 37 million facility dedicated to producing what it calls "superproteins," including cultivated meat and microbial proteins targeting precision nutrition and supplements. These are not speculative bets; they are strategic capital allocations by some of the world's largest food companies.

Key Growth Drivers
Surging Global Protein Demand: The arithmetic of population growth makes protein alternatives a business necessity, not a lifestyle choice. As conventional farming runs up against land, water, and emissions ceilings, food companies and governments are treating cultured meat as a structural solution to close the protein supply gap projected for mid-century.

Regulatory Momentum and Government Recognition: Singapore made history in February 2026 by becoming the first country to grant formal approval for cultured meat products intended for human consumption, authorizing three products across chicken and quail categories. U.S. FDA approvals already in place for certain cultivated products have similarly opened doors for North American producers. Regulatory green lights are the single most important commercial accelerator for this market, and the pace of approvals is picking up.

Rising Environmental and Ethical Pressure: Consumer awareness around the environmental footprint of industrial meat production is driving demand for alternatives. Cultured meat addresses both dimensions: lower greenhouse gas emissions and no requirement for animal slaughter. These attributes are drawing in a consumer segment that is actively willing to pay a premium, particularly in urban markets across North America, Europe, and Asia.

Surge in Intellectual Property and Research Activity: Over 360 patents focused on cultured meat have been filed or granted in the past five years, with 88% still pending approval, signaling that the technology is maturing rapidly but has significant innovation runway ahead. Institutions including Tufts University and the Good Food Institute are actively recouping cell lines from closed startups to prevent knowledge loss and accelerate development timelines globally.

Partnership and Consolidation Activity: Since 2022, more than 280 partnerships have been signed across the cultured meat industry. Companies are acquiring capabilities through M&A; JBS's acquisition of Bio.Tech.Foods in May 2022 to access its protein production technology is one clear example of this consolidation dynamic. Over 65% of the companies currently active in the market were established between 2018 and 2021, and many are now entering strategic agreements to scale production and access distribution channels.

Market Segmentation
The cultured meat market segments across source of meat, cultivation technique, form of meat, end product, application, end user, and geography. By source of meat, poultry and pork together command the largest projected share through 2050, driven by their strong nutritional profiles and broad consumer familiarity across major markets. The scaffold-based cultivation technique currently holds the leading position among production methods, because the scaffold structure provides physical support that guides tissue maturation into defined, structured forms - a quality essential for whole-cut applications.

By form of meat produced, minced meat leads the market today and is expected to retain the largest share across the forecast period, given its versatility across multiple end products including burger patties, nuggets, meatballs, and sausages. Burger patties currently account for the largest slice of the end-product segment, followed by nuggets. By application, the human food industry holds the majority of current market share, though the pet food segment is growing faster; regulatory requirements for pet food applications are less stringent and the products do not require the same three-dimensional structural quality as human-grade meat. By end user, restaurants lead today, followed by retailers and e-commerce platforms.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/cultured-meat-market/request-quote.html

Regional Insights
North America and Asia-Pacific together account for more than 95% of the global cultured meat market today. North America's position reflects early regulatory action, specifically FDA approvals that have validated food safety standards for cultivated products, alongside the concentration of well-capitalized startups and established food conglomerates investing in the space. Approximately 30% of all profiled cultured meat companies are headquartered in North America, reinforcing the region's role as the primary commercial hub. Within Asia-Pacific, which Roots Analysis projects will capture around 38% of the total market by 2050, the demand for meat is rising sharply alongside expanding middle-class populations, making it a critical volume market for the decade ahead.

Europe, while currently a smaller share of the overall market, is forecast to grow at the highest CAGR of any region, reaching 87% through 2050. That acceleration reflects a combination of anticipated new production facility openings, continued technological advancement in cultivation methods, and a strong regulatory interest in food sustainability. Within Europe, the United Kingdom has emerged as the primary hub for cultured meat companies, with notable activity from startups and research institutions.

Competitive Landscape
The cultured meat market features more than 105 companies spanning large, mid-sized, and early-stage organizations. Key players profiled include Aleph Farms, Esco Aster, GOOD Meat, Mosa Meat, UPSIDE Foods, Vow, Ants Innovate, Blue Ridge Bantham, BLUU, Finless Foods, Meatiply, MIRAI FOODS, Newform Foods, Ohayo Valley, Steakholder Foods, and The Better Butchers, among a full list of 109 companies in the complete report.

The competitive dynamic is a mix of startup disruption and incumbent consolidation. Early-stage companies are racing to solve the scale-up problem, particularly around reducing the cost of cell culture media, which remains the primary cost barrier to commercial viability. Established food giants like JBS are acquiring technology assets and building proprietary production infrastructure rather than licensing from startups. The main battleground right now is production economics and regulatory standing, with intellectual property around bioreactor design, scaffold materials, and serum-free media formulations becoming increasingly contested.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/cultured-meat-market.html

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.